[Bioundgrd] Fwd: 2003-2004 EMBS-BMES Distinguished Lecture Series--December 10th, 7pm, Rm 66-110

[Janice Chang]

>>Date: Wed, 03 Dec 2003 23:39:33 -0500
>>To: bmes-members at mit.edu, bmes-request at mit.edu
>>From: Mandy Yeung <mandyy at mit.edu>
>>Subject: 2003-2004 EMBS-BMES Distinguished Lecture Series--December 
>>10th, 7pm, Rm 66-110
>>
>>Dear colleagues and friends,
>>
>>The Boston chapter of the Institute of Electrical and Electronics Engineers
>>         (IEEE)-Engineering in Medicine and Biology Society (EMBS)
>>                                  &
>>               the MIT Biomedical Engineering Society (BMES)
>>                           proudly present:
>>
>>        *** The 2003-2004 EMBS-BMES Distinguished Lecture Series ***
>>
>>We invite you to join us for our new monthly lecture series in 
>>which we explore
>>recent developments and stimulating topics in the expanding field 
>>of biomedical
>>engineering.  In the fall, speakers from both academia and industry 
>>will introduce such
>>subjects as genes, genomics, proteomics, and systems biology.
>>
>>Our second lecture will be:
>>
>>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
>>The Emerging Biological Engineering Discipline -- New Directions 
>>and Opportunities
>>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
>>
>>Douglas A Lauffenburger, Ph.D.
>>Uncas & Helen Whitaker Professor and Director
>>Biological Engineering Division
>>Massachusetts Institute of Technology
>>
>>Wednesday, December 10th, 2003
>>7PM (Refreshments at 6:30PM)
>>MIT Building 66, 77 Massachusetts Ave., Room 66-110
>>	(For directions to MIT, please visit http://whereis.mit.edu)
>>
>>* This event is free and open to the public.*
>>
>>************************************************************************
>>
>>ABSTRACT:
>>
>>A new biology-based engineering discipline, termed Biological 
>>Engineering at MIT, is emerging which takes modern biology as its 
>>central science base and fuses it with appropriate quantitative and 
>>integrative analytical and synthetic approaches toward goals of: 
>>[a] increasing fundamental understanding of how biological systems 
>>operate; and [b] creating innovative biotechnologies directed 
>>toward a diverse spectrum of application areas -- prominently 
>>emphasizing medicine and human health, but also including other 
>>areas of societal importance.
>>
>>This talk will offer an overview of this new discipline, focusing 
>>on novel directions in research, education, and career 
>>opportunities being pursued in the MIT Biological Engineering 
>>Division.
>>
>>
>>SPEAKER BACKGROUND:
>>
>>Douglas A. Lauffenburger is Uncas & Helen Whitaker Professor of 
>>Bioengineering in the Biological Engineering [BE] Division, Biology 
>>Department, and Chemical Engineering Department and is a Member of 
>>the Center for Cancer Research, Center for Biomedical Engineering, 
>>and Biotechnology Process Engineering Center at MIT.  He serves as 
>>Director of the BE Division Director and on the Executive Committee 
>>of the MIT Computational & Systems Biology Initiative. 
>>
>>Dr. Lauffenburgerís BS and PhD degrees are in chemical engineering 
>>from the University of Illinois and the University of Minnesota, in 
>>1975 and 1979 respectively.  His major research interests are in 
>>cell engineering: the fusion of engineering with molecular cell 
>>biology. A central focus of his research program is in 
>>receptor-mediated cell communication and intracellular signal 
>>transduction, with emphasis on development of predictive 
>>computational models derived from quantitative experimental 
>>studies, for cell cue/signal/response relationships important in 
>>pathophysiology with application to drug discovery and development. 
>>Lauffenburger has coauthored a monograph entitled Receptors: Models 
>>for Binding, Trafficking & Signaling, published by Oxford 
>>University Press in 1993 and reprinted in 1996.  More than 50 
>>doctoral students and postdoctoral associates have completed their 
>>training under his supervision or co-supervision.
>>
>>Prof. Lauffenburger has served as a consultant or scientific 
>>advisory board member for Astra-Zeneca, CellPro, Entelos, Insert 
>>Therapeutics, Johnson & Johnson, Pfizer, SyStemix, the 
>>Burroughs-Wellcome Foundation, and the Whitaker Foundation.  His 
>>awards include the A.P. Colburn Award, Bioengineering Division 
>>Award, and W.H. Walker Award from AIChE, the Distinguished Lecture 
>>Award from BMES, the C.W. McGraw Award from ASEE, the Amgen Award 
>>in Biochemical Engineering from the Engineering Foundation, and a 
>>J.S. Guggenheim Fellowship, along with a number of named lectures 
>>at academic institutions.  He is a member of the National Academy 
>>of Engineering and of the American Academy of Arts & Sciences, and 
>>has served as President of the Biomedical Engineering Society, 
>>Chair of the College of Fellows of AIMBE, and on the Advisory 
>>Council for the National Institute for General Medical Sciences at 
>>NIH. 
>>
>>
>>************************************************************************
>>
>>If you have any questions, please do not hesitate to contact us.  We look
>>forward to seeing you!
>>
>>
>>Best Regards,
>>
>>Mandy Yeung					Alexis DeSieno
>>VP of Special Programs			President
>>BMES,MIT Chapter				BMES, MIT Chapter
>>mandyy at mit.edu				alexisd at mit.edu
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.mit.edu/pipermail/bioundgrd/attachments/20031204/36ae6376/attachment.htm